Status:
COMPLETED
A Prospective Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications Treated With One Suprachoroidal Stent
Lead Sponsor:
Glaukos Corporation
Conditions:
Subject With Primary Open-angle Glaucoma (POAG)
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess the efficacy and safety of one iStent supra stent in the reduction of intraocular pressure associated with primary open-angle glaucoma.
Detailed Description
The study assesses the efficacy and safety of one iStent supra stent in the reduction of intraocular pressure associated with primary open-angle glaucoma.
Eligibility Criteria
Inclusion
- Diagnosed with primary open-angle glaucoma (POAG)
- Subjects on two topical hypotensive medications
Exclusion
- Traumatic, uveitic, neovascular, or angle closure glaucoma
- Fellow eye already enrolled
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 16 2019
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01252914
Start Date
December 1 2010
End Date
December 16 2019
Last Update
September 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S.V. Malayan Ophthalmology Centre
Yerevan, Armenia, 375108